An H2S-releasing NSAID
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

ATB-346

Item No. 16234

Technical Information
Formal Name
6-methoxy-α-methyl-2-naphthaleneacetic acid, 4-(aminothioxomethyl)phenyl ester
CAS Number
1226895-20-0
Molecular Formula
C21H19NO3S
Formula Weight
Purity
≥98%
A crystalline solid
λmax
231 nm
SMILES
COC1=CC=C2C(C=CC(C(C)C(OC3=CC=C(C(N)=S)C=C3)=O)=C2)=C1
InChi Code
InChI=1S/C21H19NO3S/c1-13(21(23)25-18-8-5-14(6-9-18)20(22)26)15-3-4-17-12-19(24-2)10-7-16(17)11-15/h3-13H,1-2H3,(H2,22,26)
InChi Key
YCNMAPLPQYQJFC-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    ATB-346 is a non-steroidal anti-inflammatory drug (NSAID) that releases hydrogen sulfide (H2S) and a derivative of naproxen (Item No. 70290).1 It inhibits the proliferation of, and induces apoptosis in, A375 melanoma cells when used at a concentration of 100 µM.2 ATB-346 decreases prostaglandin E2 (PGE2) production in inflammatory exudates, reduces paw edema, and increases plasma levels of sulfide in a mouse model of zymosan-induced arthritis.1,3 It reduces the size of acetic acid-induced gastric ulcers in mice when administered at a dose of 60 µmol/kg.1 ATB-346 (30 µmol/kg) improves motor function in a mouse model of spinal cord injury.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Wallace, J.L., Caliendo, G., Santagada, V., et alMarkedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). Br. J. Pharmacol. 159(6), 1236-1246 (2010).

    2. De Cicco, P., Panza, E., Ercolano, G., et alATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo. Pharmacol. Res. 114, 67-73 (2016).

    3. Dief, A.E., Mostafa, D.K., Sharara, G.M., et alHydrogen sulfide releasing naproxen offers better anti-inflammatory and chondroprotective effect relative to naproxen in a rat model of zymosan induced arthritis. Eur. Rev. Med. Pharmacol. Sci. 19(8), 1537-1546 (2015).

    4. Campolo, M., Esposito, E., Ahmad, A., et alA hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury. The FASEB Journal 27(11), 4489-1199 (2013).